Navigation Links
Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics
Date:11/13/2007

BOTHELL, Wash., Nov. 13 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. ("Nastech") (Nasdaq: NSTK) announced today that the Board of Directors has approved the recommendation of its Special Committee to move forward with the process of establishing Nastech's wholly-owned subsidiary, MDRNA, Inc. ("MDRNA"), as an independent company. Nastech is transferring its intellectual property and agreements related to RNA interference ("RNAi") into MDRNA. The new structure will give Nastech the ability to pursue independent investment to fund MDRNA's operations. Nastech plans to pursue such funding in the near-term, subject to market conditions, and expects to retain significant ownership in MDRNA following such financing. In addition, Nastech intends, subject to change based on market conditions or future change in strategy, to thereafter issue a dividend to Nastech's shareholders of a portion of the MDRNA equity held by Nastech, and to effect the public trading of those securities through a Form 10 filing.

The planned change in corporate structure will enable Nastech to continue its focus on the development of peptide and protein drug delivery technologies while better positioning MDRNA for strategic alliances and direct investment as it develops RNAi therapeutics targeting a broad range of diseases. The establishment of MDRNA as an independent company will also allow it to be better compared and valued relative to other companies in the field of RNAi therapeutics.

"The establishment of MDRNA as an independent company will better serve our shareholders by providing a structure which will help us unlock the value of Nastech's RNAi assets as well as expedite the development of new therapeutics based on t
'/>"/>

SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
2. Nastech Pharmaceutical Company Announces the Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery
3. Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
4. Teens who see more smoking in movies may have increased risk of becoming established smokers
5. LifeNet Health Establishes The Skin & Wound Allograft Institute
6. Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology
7. AT&T Establishes New Network Services for Leading Medical Liability Insurer
8. University Hospitals Ireland Cancer Center and Funky Winkerbean Cartoonist Tom Batiuk Establish Lisas Legacy Fund for Cancer Research and Education
9. Establishment of Topps Meat Recall Registry for Victims of E. Coli Poisoning
10. Hofstra University to Establish New School of Medicine, Partnering with the North Shore-LIJ Health System
11. Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
... in Taipei, Taiwan said in a new study that "apple...in their middle age have an increased risk of deve... on 2,377 Chinese adults aged 30 and above. Some ...ypertension during the course of the 10-year study...
... is often used as a treatment for gout, may also b...ts with hepatitis virus-related end-stage liver di...he study followed 186 patients with cirrhosis of t...eived colchicine, while the others received no tre...
... been responsible for the deadly 1998–2000 outbrea... in the Democratic Republic of the Congo, accordin...gland Journal of Medicine. Daniel G. Bausch, assoc...t Tulane University School of Public Health and Tr...
... of poultry products following an outbreak of bird...rangements to allow "restricted" processed chicken...est Bengal state has been identified from where th...vestock officials said frozen or chilled chicken w...
Other Medicine News:Health News:India to Revive Exporting of Processed Chicken to Bhutan 2
(Date:9/4/2008)...uncements Remain on Schedule with Two Abstracts Ac...ta Release in November 2008, BRIDGEWATER, N.J., S...nc., a specialty pharmaceutical company focused on...ease, today announced the appointment of,Peter L. ...s., Peter Garrambone,s career includes more than ...
(Date:9/3/2008)...an College of Rheumatology Research and Education ...nificant Advances in Detecting, ... /- For the first time during its,unp...d arthritis, the,American College of Rheumatology ... information acquired from research funded by the ...
(Date:9/3/2008)...BURG, Md., Sept. 3 /- Panacea Pharmac.... Patent Number 7,413,737 covering,antibodies agai...(HAAH), a,proprietary human cancer biomarker and t... in collaboration with the Massachusetts Institute...rldwide rights to this patent,for development of h...
(Date:9/3/2008)...cal Trial Reconfirms Strong Evidence Pycnogenol(R)...g Effect on Joints Following Cessation ...ept. 3 /- According to the Center for...ommon type of arthritis,is on the rise. A new stu...,Research, reveals Pycnogenol(R), bark extract fro...
Breaking Medicine Technology:Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Ear infection superbug discovered to be resistant to all pediatric antibiotics 3850 1Ear infection superbug discovered to be resistant to all pediatric antibiotics 3850 2Ear infection superbug discovered to be resistant to all pediatric antibiotics 3850 3Ear infection superbug discovered to be resistant to all pediatric antibiotics 3850 4Ear Infections Linked to Drug Resistant Superbug 3845 1Ear Infections Linked to Drug Resistant Superbug 3845 2Ear Infections Linked to Drug Resistant Superbug 3845 3Ear Infections Linked to Drug Resistant Superbug 3845 4FORGET THE JONESES This is All About Keeping up With the Walkers as the Los Angeles Jewish Home Sends Out an Invite to Everyone Named Walker in the U 3840 1FORGET THE JONESES This is All About Keeping up With the Walkers as the Los Angeles Jewish Home Sends Out an Invite to Everyone Named Walker in the U 3840 2New Report Provides Insight Into Developments in the Market for Anxiety and Depression Therapies 3835 1New Report Provides Insight Into Developments in the Market for Anxiety and Depression Therapies 3835 2
...N DIEGO, May 22, 2007 /PRNewswire-FirstCall/ -- Ac...07 American Psychiatric,Association annual meeting...chotic, was shown to have a favorable akathisia,pr...stlessness that,manifests as an inability to sit s... medications. Iloperidone is being studied by Vand...
...Data from Picoplatin Phase 1 Colorectal and Prosta...eedings --, SOUTH SAN FRANCISCO, Calif., May 23, 2...als, Inc. , a biopharmaceutical company,focused on...2 trial,of picoplatin, the Company,s lead product ... (SCLC) will be presented in a poster,session at t...
Other Medicine Technology:Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 2Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 3Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 4Antipsychotic Iloperidone Results Show Favorable Akathisia Profile 5Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 3Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 4
...demand environments like OB/GYN, ER/Trauma, ICC/CC... delivers precision and control, plus consistent h...FESKIN* SATIN PLUS* Sterile Singles delive...excellent tactile sensitivity. The gloves are powd...
UROLOGY DRAPE. Soft translucent material for excellent shape conformity. Latex finger cot with additional adhesive ring around base. Full-width 50mm adhesive strip for secure fixing, with finger lift
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification
...the Penilab IV and the Penilab V have an exception...al studies. Model 1060 is similar to the Model 10...can one be added later. The Penilab V has a Doppl...of the accessories you'll need to get started. La...
Medicine Products: